A detailed history of Nilsine Partners, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Nilsine Partners, LLC holds 25,931 shares of ZTS stock, worth $4.53 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
25,931
Previous 25,531 1.57%
Holding current value
$4.53 Million
Previous $5.04 Billion 12.92%
% of portfolio
0.6%
Previous 0.77%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$165.67 - $199.94 $66,268 - $79,976
400 Added 1.57%
25,931 $4.39 Billion
Q4 2023

Jan 24, 2024

SELL
$151.44 - $200.09 $181,425 - $239,707
-1,198 Reduced 4.48%
25,531 $5.04 Billion
Q3 2023

Nov 01, 2023

BUY
$167.14 - $192.77 $276,950 - $319,419
1,657 Added 6.61%
26,729 $4.65 Billion
Q2 2023

Jul 21, 2023

BUY
$160.94 - $186.23 $33,153 - $38,363
206 Added 0.83%
25,072 $4.32 Billion
Q1 2023

May 10, 2023

BUY
$145.48 - $175.02 $3.62 Million - $4.35 Million
24,866 New
24,866 $4.14 Billion

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Nilsine Partners, LLC Portfolio

Follow Nilsine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nilsine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nilsine Partners, LLC with notifications on news.